Evidence map›Paper›PMID 32690865›Full record

ArticleMolecular psychiatry2021

Optogenetic manipulation of an ascending arousal system tunes cortical broadband gamma power and reveals functional deficits relevant to schizophrenia.

James M McNally, David D Aguilar, Fumi Katsuki, Leana K Radzik, Felipe L Schiffino, David S Uygun, James T McKenna, Robert E Strecker, Karl Deisseroth, Kevin M Spencer and 1 more

Abstract read
In one paragraph

Article in Molecular psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Layer 6 Corticothalamic Neurons Induce High Gamma Oscillations Through Cortico-cortical and Cortico-thalamo-cortical Pathways.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  7. Review
  8. Neuronal PAS domain 1 identifies a major subpopulation of wakefulness-promoting GABAergic neurons in the basal forebrain.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Recent Advances and Future Directions in Brain MR Imaging Studies in Schizophrenia: Toward Elucidating Brain Pathology and Developing Clinical Tools.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2022
    Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

James M McNallyDepartment of Psychiatry, VA Boston Healthcare System and Harvard Medical School, West Roxbury, Boston, MA, USA. James_McNally@hms.harvard.edu.
David D AguilarDepartment of Psychiatry, VA Boston Healthcare System and Harvard Medical School, West Roxbury, Boston, MA, USA.
Fumi KatsukiDepartment of Psychiatry, VA Boston Healthcare System and Harvard Medical School, West Roxbury, Boston, MA, USA.
Leana K RadzikDepartment of Neuroscience, Stonehill College, Easton, MA, USA.
Felipe L SchiffinoDepartment of Psychiatry, VA Boston Healthcare System and Harvard Medical School, West Roxbury, Boston, MA, USA.
David S UygunDepartment of Psychiatry, VA Boston Healthcare System and Harvard Medical School, West Roxbury, Boston, MA, USA.
James T McKennaDepartment of Psychiatry, VA Boston Healthcare System and Harvard Medical School, West Roxbury, Boston, MA, USA.
Robert E StreckerDepartment of Psychiatry, VA Boston Healthcare System and Harvard Medical School, West Roxbury, Boston, MA, USA.ORCID http://orcid.org/0000-0002-9453-3670
Karl DeisserothPsychiatry and Behavioral Sciences/Bioengineering, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-9440-3967
Kevin M SpencerDepartment of Psychiatry, VA Boston Healthcare System and Harvard Medical School, Jamaica Plain, Boston, MA, USA.ORCID http://orcid.org/0000-0002-5500-7627
Ritchie E BrownDepartment of Psychiatry, VA Boston Healthcare System and Harvard Medical School, West Roxbury, Boston, MA, USA.

Funding

Wakefulness and Forebrain Activation by Orexin NeuronsP01HL095491 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI CHAMBERLIN, NANCY L · 2010 to 2019
$25.1M
TRAINING IN SLEEP, CIRCADIAN &RESPIRATORY NEUROBIOLOGYT32HL007901 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Charles A Czeisler · 1998 to 2026
$18.5M
Stuart T. Hauser Research Training Program in Biological and Social Psychiatry.T32MH016259 · NIMH · JUDGE BAKER CHILDREN'S CENTER · PI Marek Kubicki, Martha E. Shenton · 1985 to 2026
$8.4M
THE SYNAPTIC BASIS OF SLEEP CYCLE CONTROLR01MH039683 · NIMH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI BROWN, RITCHIE EDWARD · 1985 to 2017
$3.8M
THE SYNAPTIC BASIS OF SLEEP CYCLE CONTROLR37MH039683 · NIMH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI MCCARLEY, ROBERT W · 1987 to 2006
$3.1M
Electrophysiological Endophenotypes of Schizophrenia in Mouse and ManR01MH093450 · NIMH · GALENEA CORPORATION · PI LEVIN, MARGARET, SPENCER, KEVIN M · 2012 to 2016
$2.9M
vGLUT2-Tomato mice: a novel tool to study Basal Forebrain Glutamate NeuronsR21NS093000 · NINDS · HARVARD MEDICAL SCHOOL · PI BROWN, RITCHIE EDWARD · 2015 to 2016
$354k
Optogenetic dissection of basal forebrain neurons involved in sleep homeostasisR21NS079866 · NINDS · HARVARD MEDICAL SCHOOL · PI BASHEER, RADHIKA · 2012 to 2013
$341k
Basal forebrain parvalbumin neurons regulate attention by controlling cortical oscillationsF32MH119838 · NIMH · HARVARD MEDICAL SCHOOL · PI SCHIFFINO, FELIPE LOPES · 2020 to 2020
$72k
BLRD Research Career Scientist Award ApplicationIK6BX005714 · VA · VA BOSTON HEALTH CARE SYSTEM · PI STRECKER, ROBERT E · 2021 to 2025
–
Using CRISPR-Cas9 genetic abscission in vivo to study the role of GABA-A receptors of the thalamic reticular nucleus in regulating non-rapid-eye-movement sleep and drug induced sleepIK2BX004905 · VA · VA BOSTON HEALTH CARE SYSTEM · PI UYGUN, DAVID SAMUEL · 2020 to 2024
–
Improving cortical function & cognition in schizophrenia by modulation of mGluR5IK2BX002130 · VA · VA BOSTON HEALTH CARE SYSTEM · PI MCNALLY, JAMES M · 2014 to 2018
–
BLRD VA I01 BX001356BLRD VA I01 BX002774BLRD VA I01 BX004500BLRD VA I01 BX004673BLRD VA IK2 BX002130BLRD VA IK2 BX004905BLRD VA IK6 BX005714CSRD VA I01 CX001443NHLBI NIH HHS P01 HL095491NHLBI NIH HHS T32 HL007901NIMH NIH HHS F32 MH119838NIMH NIH HHS R01 MH039683NIMH NIH HHS R01 MH093450NIMH NIH HHS T32 MH016259NINDS NIH HHS R21 NS079866NINDS NIH HHS R21 NS093000
6 · The paper itself

Abstract

Increases in broadband cortical electroencephalogram (EEG) power in the gamma band (30-80 Hz) range have been observed in schizophrenia patients and in mouse models of schizophrenia. They are also seen in humans and animals treated with the psychotomimetic agent ketamine. However, the mechanisms which can result in increased broadband gamma power and the pathophysiological implications for cognition and behavior are poorly understood. Here we report that tonic optogenetic manipulation of an ascending arousal system bidirectionally tunes cortical broadband gamma power, allowing on-demand tests of the effect on cortical processing and behavior. Constant, low wattage optogenetic stimulation of basal forebrain (BF) neurons containing the calcium-binding protein parvalbumin (PV) increased broadband gamma frequency power, increased locomotor activity, and impaired novel object recognition. Concomitantly, task-associated gamma band oscillations induced by trains of auditory stimuli, or exposure to novel objects, were impaired, reminiscent of findings in schizophrenia patients. Conversely, tonic optogenetic inhibition of BF-PV neurons partially rescued the elevated broadband gamma power elicited by subanesthetic doses of ketamine. These results support the idea that increased cortical broadband gamma activity leads to impairments in cognition and behavior, and identify BF-PV activity as a modulator of this activity. As such, BF-PV neurons may represent a novel target for pharmacotherapy in disorders such as schizophrenia which involve aberrant increases in cortical broadband gamma activity.

Indexed as

Basal ForebrainSchizophreniaAnimalsArousalElectroencephalographyHumansMiceOptogeneticsParvalbuminsParvalbumins

Identifiers

PMID32690865
PMCPMC7855059

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.